Synopsis Humira is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Global Humira Biosimilar market is projected to reach US$ 958.9 million in 2029, increasing from US$ 421 milli.....
Synopsis Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Global Adalimumab Monoclonal Antibody Biosimilar market is projected to reach US$ 958.9 million in 2029,.....
Synopsis Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Global Adalimumab (Humira) and Biosimilar market is projected to reach US$ 15520 million in 2029, increa.....
Synopsis Avastin Biosimilar is a humanized monoclonal antibody. It inhibits angiogenesis (the formation of new blood vessels) by blocking the action of vascular endothelial growth factor A (VEGF-A). Bevacizumab can therefore slow the growth of new blood .....
Synopsis Avastin Biosimilar is a humanized monoclonal antibody. It inhibits angiogenesis (the formation of new blood vessels) by blocking the action of vascular endothelial growth factor A (VEGF-A). Bevacizumab can therefore slow the growth of new blood .....
Synopsis Etanercept is a medication used to manage and treat autoimmune conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis. It is a biologic fusion protein in the TNF .....
Synopsis Etanercept is a medication used to manage and treat autoimmune conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis. It is a biologic fusion protein in the TNF .....
Synopsis EPOGEN® is a prescription medication that is used to treat anemia for people with CKD on dialysis by helping the body create more red blood cells. Global Epogen and Biosimilar market is projected to reach US$ 534.8 million in 2029, i.....
Synopsis Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. Global Herceptin (Trastuzumab) and Biosimilar market is projected to reach US$ 6303.7 million in 2029.....
Synopsis Ranibizumab is a medication used to manage and treat neovascular age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, myopic choroidal neovascularization, and diabetic retinopathy. Glo.....
